EMEllen H. A. van Den Munckhof

Ellen H. A. van Den Munckhof

*This is an algorithmically generated author record based on publicly available information.

Ellen H. A. van Den Munckhof has a total of 36 co-authors. Here are the top co-authors by number of shared publications:

  • Maurine A. Leverstein-Van Hall

    Department of Medical Microbiology, Haaglanden Medical Center, The Hague, The Netherlands

    3 shared publications
  • Wim G. V. Quint

    DDL Diagnostic Laboratory, Visseringlaan 25, 2288, ER, Rijswijk, The Netherlands

    3 shared publications
  • Anco Molijn

    DDL Diagnostic Laboratory, Rijswijk, The Netherlands

    2 shared publications
  • Cornelis W. Knetsch

    DDL Diagnostic Laboratory, Rijswijk, The Netherlands

    2 shared publications
  • Ed J. Kuijper

    Department of Medical Microbiology, Leiden University Medical Center, The Netherlands

    2 shared publications
  • Kim E. Boers

    Department of Gynecology, Haaglanden Medical Center, The Hague, The Netherlands

    2 shared publications

Latest Publications

  • Open Access

    A Direct Comparative Analysis of HPV DNA with Single-Molecule RNA and p16INK4a Protein Expression in Lichen Sclerosus: Implications for Diagnostics and Pathogenesis

    by Georgios Kravvas, Boyu Xie, Clarisse Ganier, Henk van Den Munckhof, Ellen van Den Munckhof, Maurits de Koning, Sandra Jerkovic Gulin, Alex Freeman, Aiman Haider, Hussain Alnajjar, et al.


  • Open Access

    Differences in the Urinary Microbiome of Patients with Overactive Bladder Syndrome with and without Detrusor Overactivity on Urodynamic Measurements

    by Aida Javan Balegh Marand, Cléo Baars, John Heesakkers, Ellen van Den Munckhof, Morteza Ghojazadeh, Mohammad Sajjad Rahnama’i, Dick Janssen

    Introduction: It has been hypothesized that the urinary microbiome might play an important role in OAB. Studies have been conducted on the association between OAB symptoms and the microbiome, although a possible causality still has to be determined. Material and Methods: In this study, 12 female patients, ≥18 years of age, with ‘OAB DO+’ and 9 female patients with ‘OAB DO-’ were included. Patients were excluded if they met one of the following exclusion criteria: bladder tumors and previous bladder operations; sacral neuromodulation; injection of Botox in the bladder; and TOT or TVT operations. Urine samples were collected and stored with patient informed consent and with the approval of the Hospital Ethical Review Board (Arnhem–Nijmegen). All OAB patients underwent urodynamics before collecting urine samples, and the diagnosis of detrusor overactivity was confirmed by two individual urologists. In addition, samples from 12 healthy controls who did not undergo urodynamic evaluation were analyzed. The 16S rRNA V1–V2 region amplification and gel electrophoresis were used to determine the microbiota. Results: 12 of the OAB patients had DO shown on their urodynamic studies; the remaining 9 patients had a normoactive detrusor on their urodynamic measurements. Overall, there were no substantial differences among the demographic characteristics of the subjects. The samples were classified as the following: 180 phyla, 180 classes, 179 orders, 178 families, 175 genera, and 138 species. The least commonly observed phyla were Proteobacteria, with an average presence of 10%, followed by Bacteroidetes with 15%, Actinobacteria with 16%, and Firmicutes with 41%. Most of the sequences could be classified according to the genus level for each sample. Discussion: Significant differences were observed in the urinary microbiome of patients with overactive bladder syndrome who have detrusor overactivity on urodynamics compared to OAB patients without detrusor overactivity and matched controls. OAB patients with detrusor overactivity have a significantly less diverse microbiome and show a higher proportion of Lactobacillus, particularly Lactobacillus iners. The results imply that the urinary microbiome could be involved in the pathogenesis of a specific phenotype of OAB. The urinary microbiome could be a new starting point to study the causes and treatments of OAB.


  • Developing an algorithm for the diagnosis of abnormal vaginal discharge in a dutch clinical setting: a pilot study

    by Ellen H.A. van Den Munckhof, Rosalie L. van Sitter, Ronald F. Lamont, Saskia le Cessie, Ed J. Kuijper, Cornelis W. Knetsch, Anco Molijn, Wim G.V. Quint, Kim E. Boers, Maurine A. Leverstein-Van Hall


  • Open Access

    Nasal microbiota dominated by Moraxella spp. is associated with respiratory health in the elderly population: a case control study

    by Ellen H. A. van Den Munckhof, Harriet C. Hafkamp, Josephine de Kluijver, Ed J. Kuijper, Maurits N. C. de Koning, Wim G. V. Quint, Cornelis W. Knetsch

    Background: The elderly (≥65 years) are one of the populations most at risk for respiratory tract infections (RTIs). The aim of this study was to determine whether nasal and/or oropharyngeal microbiota profiles are associated with age and RTIs. Methods: Nasal and oropharyngeal swabs of 152 controls and 152 patients with an RTI were included. The latter group consisted of 72 patients with an upper respiratory tract infection (URTI) and 80 with a lower respiratory tract infection (LRTI). Both nasal and oropharyngeal swabs were subjected to microbiota profiling using amplicon sequencing of the 16S rRNA gene. Moraxella species were determined using quantitative real-time PCR and culture. Results: Based on the microbiota profiles of the controls and the patients with an RTI, eight nasal and nine oropharyngeal microbiota clusters were defined. Nasal microbiota dominated by either Moraxella catarrhalis or Moraxella nonliquefaciens was significantly more prevalent in elderly compared to mid-aged adults in the control group (p = 0.002). Dominance by M. catarrhalis/nonliquefaciens was significantly less prevalent in elderly with an LRTI (p = 0.001) compared to controls with similar age. Conclusions: Nasal microbiota dominated by M. catarrhalis/nonliquefaciens is associated with respiratory health in the elderly population.


  • Comparison of Amsel criteria, Nugent score, culture and two CE-IVD marked quantitative real-time PCRs with microbiota analysis for the diagnosis of bacterial vaginosis

    by Ellen H. A. van Den Munckhof, Rosalie L. van Sitter, Kim E. Boers, Ronald F. Lamont, René Te Witt, Saskia le Cessie, Cornelis W. Knetsch, Leen-Jan van Doorn, Wim G. V. Quint, Anco Molijn, et al.

    Bacterial vaginosis (BV) is a common gynaecological condition. Diagnosis of BV is typically based on Amsel criteria, Nugent score and/or bacterial culture. In this study, these conventional methods and two CE-IVD marked quantitative real-time (q)PCR assays were compared with microbiota analysis for the diagnosis of BV. Eighty women were evaluated for BV during two sequential hospital visits by Amsel criteria, Nugent score, culture, the AmpliSens® Florocenosis/Bacterial vaginosis-FRT PCR kit (InterLabService, Moscow, Russia), and the BD MAX™ Vaginal Panel (BD Diagnostics, MD, USA). Microbiota analysis based on amplicon sequencing of the 16S ribosomal RNA gene was used as reference test. The microbiota profile of 36/115 (31%) included cases was associated with BV. Based on microbiota analysis, the sensitivity of detecting BV was 38.9% for culture, 61.15% for Amsel criteria, 63.9% for Nugent score and the BD MAX assay, and 80.6% for the AmpliSens assay, while the specificity of all methods was ≥ 92.4%. Microbiota profiles of the cases with discrepant results between microbiota analysis and the diagnostic methods were variable. All five diagnostic methods missed BV positive cases with a relatively high abundance of the genus Alloscardovia, Bifidobacterium, or Dialister, which were categorised as unspecified dysbiosis by the AmpliSens assay. Compared to Amsel criteria, Nugent score, culture, and the BD MAX assay, the AmpliSens assay was most in agreement with microbiota analysis, indicating that currently, the AmpliSens assay may be the best diagnostic method available to diagnose BV in a routine clinical setting.


  • Evaluation of a stepwise approach using microbiota analysis, species-specific qPCRs and culture for the diagnosis of lower respiratory tract infections

    by Ellen H. A. van Den Munckhof, Maurits N. C. de Koning, Wim G. V. Quint, Leen-Jan van Doorn, Maurine A. Leverstein-Van Hall

    In clinical practice, the diagnosis of lower respiratory tract infections (LRTIs) is based on culture. The aim of this study was to evaluate whether a stepwise approach using microbiota analysis, species-specific quantitative real-time (q)PCRs and culture has the potential to be a more accurate and efficient diagnostic approach than culture alone. Sixty-two sputa obtained in a routine clinical setting from patients with a suspected LRTI were included. All sputa were analysed by culture, microbiota analysis based on the 16S ribosomal RNA gene and multiple species-specific qPCRs. Microbiota and culture data were compared to investigate whether cut-off values for microbiota analysis could be determined. For microbiota analysis, a relative abundance of 25% was identified as the cut-off value for the detection of both genera Streptococcus and Haemophilus. Microbiota analysis combined with species-specific qPCRs resulted in a significant increase in the number of positive sputa (73% vs 58%; p = 0.003) as well as in the number of identified pathogens (51 vs 37; p = 0.049) compared to culture. A stepwise approach using microbiota analysis, species-specific qPCRs and culture has the potential to be used in clinical settings for the diagnosis of LRTIs in the near future.